Skip to content

Effect of Dashamoola ksheera paka and R P vati in Periods pain

Comparative clinical study to evaluate the efficacy of Dashamoola Ksheera Paka and Rajapravartini Vati followed by Matrabasti in Udavartini Yoni Vyapath w.s.r Primary Dysmenorrhoea - nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067277
Enrollment
120
Registered
2024-05-14
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z608- Other problems related to social environment

Interventions

None listed

Sponsors

Dr Lakshmi D R
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age Group Menarche to 30 years 2.Patients with "Pratyatma Lakshana" of Udavartini Yoni Vyapath 3.patient who are willing to participate in our treatment

Exclusion criteria

Exclusion criteria: 1. Patients with Chronic general illness and Systemic disorders. 2.Patients with intrauterine contraceptive devices, oral contraceptives. 3.Any Congenital anomalies 4.Any uterine pathology - fibroid, Adenomyosis, endometriosis, PID, Menorrhagia etc.

Design outcomes

Primary

MeasureTime frame
1.Dashamoola Ksheera paka followed by Moorchita taila matra basti is not effective in Udavartini Yoni Vyapath. 2.Dashamoola Ksheera paka followed by Moorchita taila matra basti is effective in Udavartini Yoni Vyapath 3.Rajapravartini Vati followed by Murchita taila matra Basti is not effective in Udavartini Yoni Vyapath 4.Rajapravartini Vati followed by Murchita taila matra Basti is effective in Udavartini Yoni Vyapath.Timepoint: 3 months

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactDr Sridevi Swamy

N K Jabshetty Ayurvedic Medical College & P G Center Bidar

drshrideviswamy@gmail.com9945572704

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026